Analysis of protease‐activated receptor‐1 and ‐2 in human scar formation

Protease‐activated receptor (PAR)‐1 and PAR‐2 are reported to contribute to the fibrotic process in a number of organs, including lung, liver, pancreas, and kidney. The aim of this study was to localize expression and biological activity of PAR‐1 and PAR‐2 in normal and pathological cutaneous scars. First, we investigated the immunohistochemical expression of PAR‐1 and PAR‐2 proteins in a series of human normal scars (NS, n = 10), hypertrophic scars (HS, n = 10), and keloids (K, n = 10). Expression of PAR‐1 and PAR‐2 was observed in all types of scar. Specifically, in HS and K, diffuse PAR‐1 and PAR‐2 positivity was found in dermal cellular areas composed of myofibroblasts, while no or minor staining was observed in the scattered fibroblasts embedded in abundant extracellular matrix in the context of the more collagenous nodules, irrespective of the type of scar. The hyperplastic epidermis overlying K was also found to be strongly PAR‐1 and PAR‐2 positive, whilst in most NS and HS the epidermis was faintly to moderately stained. Second, ribonuclease protection assay on paraffin‐embedded specimens showed overexpression of PAR‐1 and PAR‐2 mRNA in K compared to NS and HS. Third, cultured human fibroblasts exposed to TGF‐β1 expressed a myofibroblast phenotype associated with overexpression of PAR‐2, while PAR‐1 expression was unaffected. Intracellular Ca2+ mobilization by PAR‐2 agonists in myofibroblasts was increased as compared to fibroblasts, whereas the effect of PAR‐1 agonists was unchanged. Our in vivo study indicates that PAR‐1 and PAR‐2 are expressed in cells involved in physiological and pathological scar formation and suggests that in vitro overexpression and exaggerated functional response of PAR‐2 may play a role in the function of myofibroblasts in scar evolution from a physiological repair process to a pathological tissue response. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[2]  M. Artuc,et al.  Expression of prothrombin, thrombin and its receptors in human scars , 2006, Experimental dermatology.

[3]  George Broughton,et al.  The Basic Science of Wound Healing , 2006, Plastic and reconstructive surgery.

[4]  M. Hollenberg,et al.  Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma. , 2005, Human pathology.

[5]  Bishara S Atiyeh,et al.  Keloid or Hypertrophic Scar: The Controversy: Review of the Literature , 2005, Annals of plastic surgery.

[6]  R. Johns,et al.  Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. , 2005, The American journal of pathology.

[7]  A. Mukhopadhyay,et al.  Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast‐populated collagen lattices , 2005, The British journal of dermatology.

[8]  David W. Johnson,et al.  Thrombin stimulates proinflammatory and proliferative responses in primary cultures of human proximal tubule cells. , 2005, Kidney international.

[9]  A. Masamune,et al.  Protease-Activated Receptor-2-Mediated Proliferation and Collagen Production of Rat Pancreatic Stellate Cells , 2005, Journal of Pharmacology and Experimental Therapeutics.

[10]  Jianhua Zhang,et al.  Protease-activated receptor-2 (PAR-2) expression in human fibroblasts is regulated by growth factors and extracellular matrix. , 2004, The Journal of investigative dermatology.

[11]  M. Longaker,et al.  Complex epithelial–mesenchymal interactions modulate transforming growth factor‐β expression in keloid‐derived cells , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[12]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[13]  N. Bunnett,et al.  Protease-activated receptors: contribution to physiology and disease. , 2004, Physiological reviews.

[14]  V. Moulin,et al.  Normal skin wound and hypertrophic scar myofibroblasts have differential responses to apoptotic inductors , 2004, Journal of cellular physiology.

[15]  G. Caliendo,et al.  PAR1 antagonism protects against experimental liver fibrosis. Role of proteinase receptors in stellate cell activation , 2004, Hepatology.

[16]  A. Desmoulière,et al.  Normal and Pathologic Soft Tissue Remodeling: Role of the Myofibroblast, with Special Emphasis on Liver and Kidney Fibrosis , 2003, Laboratory Investigation.

[17]  L. Gesualdo,et al.  Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis. , 2003, Journal of the American Society of Nephrology : JASN.

[18]  G. Gabbiani,et al.  The myofibroblast in wound healing and fibrocontractive diseases , 2003, The Journal of pathology.

[19]  M. Gaca,et al.  Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors. , 2002, Journal of hepatology.

[20]  S. Kuptsova,et al.  Immobilized Thrombin Receptor Agonist Peptide Accelerates Wound Healing in Mice , 2001, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[21]  S. Phan,et al.  Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. , 2001, Current pharmaceutical design.

[22]  M. D'Andrea,et al.  Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. , 2001, The American journal of pathology.

[23]  W. Timens,et al.  Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars , 2001, The Journal of pathology.

[24]  G. D. Hunter,et al.  Proteinase-activated receptors. , 2001, Pharmacological reviews.

[25]  M. Longaker,et al.  Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. , 2001, Plastic and reconstructive surgery.

[26]  F. Carraro,et al.  Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation , 1999, Journal of cellular physiology.

[27]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[28]  P. C. van de Kerkhof,et al.  Hypertrophic scarring is associated with epidermal abnormalities: an immunohistochemical study , 1998, The Journal of pathology.

[29]  G. Saed,et al.  Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. , 1998, Archives of dermatology.

[30]  I. Leigh,et al.  Activated keratinocytes in the epidermis of hypertrophic scars. , 1998, The American journal of pathology.

[31]  S. M. Baker,et al.  Characterization of Protease-activated Receptor-2 Immunoreactivity in Normal Human Tissues , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  T. K. Hunt,et al.  Mice lacking the thrombin receptor, PAR1, have normal skin wound healing. , 1997, The American journal of pathology.

[33]  A. Ghahary,et al.  Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. , 1997, The Surgical clinics of North America.

[34]  C. Derian,et al.  Evidence for the presence of a protease-activated receptor distinct from the thrombin receptor in human keratinocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Phan,et al.  Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. , 1995, The Journal of investigative dermatology.

[36]  R. Diegelmann,et al.  Keloid fibroblasts exhibit an altered response to TGF-beta. , 1992, The Journal of investigative dermatology.

[37]  M. Robson,et al.  Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. , 1992, The Journal of clinical investigation.

[38]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[39]  M. Hollenberg,et al.  Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[40]  Rintala Ae.  Keloid or Hypertrophic scar , 1996 .